Which is more profitable, Eli Lilly or Takeda Pharmaceutical?

Eli Lilly keeps more of every sale as profit.

Which grows faster, Eli Lilly or Takeda Pharmaceutical?

Eli Lilly grew its sales faster in recent years.

Which is cheaper, Eli Lilly or Takeda Pharmaceutical?

Eli Lilly costs less for each unit of yearly profit (lower P/E).

Which has less debt, Eli Lilly or Takeda Pharmaceutical?

Eli Lilly would need fewer years of earnings to pay off its debt.

Eli LillyLLYvs

Takeda PharmaceuticalTAK

Eli Lilly vs Takeda Pharmaceutical stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Eli Lilly is more profitable, grows faster, is cheaper for its profits and has less debt.

Side by side

	Eli Lilly	Takeda Pharmaceutical
	$1.29 trillion	$68.5 billion
	31.7%	2.4%
	+21.6%	+8.7%
	62.3×	101.3×
	1.1 years	5.9 years
	34.8%	0.0%
	0.6%	2.8%

Open Eli Lilly Open Takeda Pharmaceutical

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Eli Lilly vs Thermo Fisher Scientific · Eli Lilly vs UCB SA · Eli Lilly vs UnitedHealth · Eli Lilly vs Vertex Pharmaceuticals